ANIXA BIOSCIENCES, INC. Treasury Stock, Value
ANIXA BIOSCIENCES, INC. (ANIX) had Treasury Stock, Value of $6.00 thousand as of 2025-01-31, per its 10-Q filed 2025-03-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2026-01-12
- 2025-01-31: Treasury Stock, Value $6.00K.
- 2024-10-31: Treasury Stock, Value $6.00K.
| Period end | Treasury Stock, Value |
|---|---|
| 2025-01-31 | $6.00K 10-Q · filed 2025-03-11 |
| 2024-10-31 | $6.00K 10-K · filed 2026-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |